Alexander Cheung - Concepedia

Author

Alexander Cheung

UCSF Helen Diller Family Comprehensive Cancer Center ORCID

Also Known As

A Cheung, A T Cheung, A. Cheung, A. T.W. Cheung, A. T.W. Cheung, AT Cheung, Alexander Cheung, Anthony Cheung

146

Publications

926

Citations

H-Index

Concepts

All Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center University of California, San Francisco Parker Institute for Cancer Immunotherapy The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute

About

Alexander Cheung is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in immunology, medicine, and tumor immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	136
2	Immunology	4	4	136
3	Education	1	1	91
4	Allergy	1	1	91
5	Endocrinology	1	1	91

Alexander Cheung

Publications

794

Citations

H-Index

Page 1

	Year	Citations
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes Maha K. Rahim, Trine Line Hauge Okholm, Kyle B. Jones, Cell	2023	370
Distribution of galanin immunoreactivity in the respiratory tract of pig, guinea pig, rat, and dog. Alexander Cheung, J.M. Polak, F E Bauer, Thorax ImmunologyGlycobiologyVeterinary ResearchEducationPorcine Intestine	1985	91
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer Meenal Sinha, Li Zhang, Sumit K. Subudhi, Journal for ImmunoTherapy of Cancer	2021	70
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, The Lancet Oncology	2023	69
Presentation and subsequent publication rates of phase I oncology clinical trials Luis H. Camacho, Jennifer Bacik, Alexander Cheung, Cancer	2005	55
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis Bridget P. Keenan, Elizabeth McCarthy, Arielle Ilano, Cell Reports	2022	34
CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy Guy Ledergor, Zenghua Fan, Elizabeth McCarthy, Blood Advances	2024	31
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer Atish D. Choudhury, Lucia Kwak, Alexander Cheung, Cancer Immunology Research	2024	29
Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy Li Zhang, Jason Cham, James V. Cooley, Journal of Immunological Methods ImmunologyPathologyImmunotherapeuticsImmune Cell TherapyImmunotherapy	2021	17
Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC). Robin Kate Kelley, Emily Mitchell, Spencer C. Behr, Journal of Clinical Oncology ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy	2018	14

Page 1